Create your Personal Health Record and unlock support built around you
- Treatments and trials you qualify for
- Education for your stage of care
- Financial support for your medications
- Solutions to your side effects
Bile Duct Cancer Screening
Bile Duct Cancer Screening
Cancer screening means looking for cancer before symptoms develop. There is currently no routine screening test recommended for bile duct cancer in the general population. Because cholangiocarcinoma is rare, screening everyone would be unlikely to provide more benefit than harm.
THE BASICS: There is no routine bile duct cancer screening program for people at average risk. People at substantially increased risk, particularly those with primary sclerosing cholangitis, may undergo specialized surveillance.
Is there a screening test for bile duct cancer?
There is no single blood test, scan, or procedure proven to reliably screen the general population for cholangiocarcinoma. CA 19-9 is sometimes elevated in bile duct cancer, but it cannot be used alone as a screening test because many noncancerous conditions can also increase it.
Who may need surveillance?
People with certain conditions have a much higher risk than the general population. The most important example is primary sclerosing cholangitis. People with PSC may be monitored at specialized centers using combinations of:
Imaging
MRI or MRCP
Blood tests
CA 19-9
Additional testing when abnormalities are detected
The exact surveillance strategy varies according to individual risk and medical history.
What about bile duct cysts?
People with choledochal cysts or certain congenital bile duct abnormalities may also require ongoing monitoring, even after surgical treatment.
Screening versus diagnostic testing
Screening is performed before symptoms occur. If you develop jaundice, unexplained weight loss, dark urine, pale stool, persistent itching, or abdominal pain, your doctor may order tests to determine the cause. That is considered diagnostic testing, not screening.